Home » Topics » Regulatory » Patents

Patents
RSS

Allelix develops antiinflammatory peptides

Jan. 29, 1997

HOP-1 claimed by Signal for treatment of CNS disorders

Jan. 29, 1997

Water-soluble camptothecin analogue reported by SKB

Jan. 29, 1997

Warner-Lambert develops antiretroviral agents

Jan. 29, 1997

RPR discloses novel polypeptides for cancer

Jan. 28, 1997

Thrombin inhibitors from BioChem Pharma

Jan. 28, 1997

Antibacterial and antineoplastic agents developed by Abbott

Jan. 28, 1997

Pharmacia & Upjohn claims camptothecin derivatives

Jan. 28, 1997

COX-2 inhibitors reported by Merck Frosst

Jan. 28, 1997

GRF analogues developed for growth hormone deficiencies

Jan. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026